The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells.

Constitutive activation of the ras oncoprotein plays a critical role in cancer invasion and metastasis. Particularly, ras-related protease expression such as the serine protease urokinase plasminogen activator (u-PA) has been implicated in mediating cancer cell invasion. Previous studies have shown that ras-mediated u-PA expression is regulated through the mitogen- (MAPK) and stress-activated protein kinase (SAPK) signal transduction pathways extracellular signal-regulated kinase (ERK) and c-Jun-activating kinase (JNK). We therefore asked the question, if ras-related cell invasion might additionally require the third MAPK/SAPK signal transduction cascade, p38. Indeed, we found that ras induces invasion based on the activation of certain p38 protein kinase isoforms, in particular, p38alpha. Moreover, ras activation through transient or stable expression of a Ha-rasEJ mutant induced the expression of u-PA. This was found to be a consequence of an increase of u-PA m-RNA, which was paralleled by only a modest activation of the u-PA promoter. In conclusion, we provide evidence for the requirement of a novel ras-p38alpha-u-PA pathway for ras-dependent cellular invasion.

[1]  R. Storer,et al.  Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D T Denhardt,et al.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.

[3]  E. Lengyel,et al.  Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor* , 1999, The Journal of Biological Chemistry.

[4]  S. Green,et al.  PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity , 1992, Neuron.

[5]  Jiahuai Han,et al.  Involvement of the MKK6-p38γ Cascade in γ-Radiation-Induced Cell Cycle Arrest , 2000, Molecular and Cellular Biology.

[6]  Bai-Lin Wu,et al.  High Intensity ras Signaling Induces Premature Senescence by Activating p38 Pathway in Primary Human Fibroblasts* , 2004, Journal of Biological Chemistry.

[7]  Shuang Huang,et al.  Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[8]  G. Nicolson,et al.  Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes. , 1990, Oncogene.

[9]  Shuang Huang,et al.  Sequential Activation of the MEK-Extracellular Signal-Regulated Kinase and MKK3/6-p38 Mitogen-Activated Protein Kinase Pathways Mediates Oncogenic ras-Induced Premature Senescence , 2002, Molecular and Cellular Biology.

[10]  E. A. O'neill,et al.  Molecular basis for p38 protein kinase inhibitor specificity. , 1998, Biochemistry.

[11]  E. Martín-Blanco.  p38 MAPK signalling cascades: ancient roles and new functions , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  P. Verde,et al.  A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. , 1992, The EMBO journal.

[13]  L. McCabe,et al.  p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose* , 2002, The Journal of Biological Chemistry.

[14]  E. Goldsmith,et al.  Structural basis of inhibitor selectivity in MAP kinases. , 1998, Structure.

[15]  Jiahuai Han,et al.  The primary structure of p38 gamma: a new member of p38 group of MAP kinases. , 1996, Biochemical and biophysical research communications.

[16]  J. Gutkind,et al.  Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts* , 1999, The Journal of Biological Chemistry.

[17]  L. Peso,et al.  The Ras family of GTPases in cancer cell invasion , 2000, Cellular and Molecular Life Sciences CMLS.

[18]  J. Brenton,et al.  Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. , 2002, Cancer Research.

[19]  Jiahuai Han,et al.  p38 Isoforms Have Opposite Effects on AP-1-dependent Transcription through Regulation of c-Jun , 2003, The Journal of Biological Chemistry.

[20]  J. Zhang,et al.  Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. , 1992, Cancer research.

[21]  Eun-Jung Lee,et al.  p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. , 2003, Cancer research.

[22]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[23]  P. Verde,et al.  Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate , 1999, Molecular and Cellular Biology.

[24]  M. Gaestel,et al.  In the Cellular Garden of Forking Paths: How p38 MAPKs Signal for Downstream Assistance , 2002, Biological chemistry.

[25]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[26]  C. Zhang,et al.  Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. , 1997, The Journal of biological chemistry.

[27]  G. Nemerow,et al.  Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity* , 2000, The Journal of Biological Chemistry.

[28]  A. Sabichi,et al.  Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene. , 1995, Oncogene.

[29]  H. Kung,et al.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein , 1984, Nature.

[30]  Lajos Pusztai,et al.  Prognostic significance of phosphorylated P38 mitogen‐activated protein kinase and HER‐2 expression in lymph node‐positive breast carcinoma , 2004, Cancer.

[31]  C. Flaitz,et al.  PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma , 1999, British Journal of Cancer.

[32]  A. Fornace,et al.  Loss of Oncogenic H-ras-Induced Cell Cycle Arrest and p38 Mitogen-Activated Protein Kinase Activation by Disruption of Gadd45a , 2003, Molecular and Cellular Biology.

[33]  Jiahuai Han,et al.  The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling* , 2000, The Journal of Biological Chemistry.

[34]  R. Somwar,et al.  An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes* , 1999, The Journal of Biological Chemistry.

[35]  Y. Nagamine,et al.  UV Irradiation Induces the Murine Urokinase-Type Plasminogen Activator Gene via the c-Jun N-Terminal Kinase Signaling Pathway: Requirement of an AP1 Enhancer Element , 1998, Molecular and Cellular Biology.

[36]  F. Prinz,et al.  Quantification of VP22‐GFP spread by direct fluorescence in 15 commonly used cell lines , 1999, The journal of gene medicine.